<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04881058</url>
  </required_header>
  <id_info>
    <org_study_id>7012-BDPM-2021</org_study_id>
    <nct_id>NCT04881058</nct_id>
  </id_info>
  <brief_title>Post Market Clinical Follow Up Study to Collect Additional Data and Imaging</brief_title>
  <official_title>Post Market Clinical Follow Up Study to Collect Additional Data and Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intended use of the PicoSure device with focus lens array used in this study is to assess&#xD;
      images to support additional marketing claims for the treatment of pigmentation and mild to&#xD;
      moderate wrinkles.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 10 subjects will be enrolled at 1 study center. Subjects will attend a&#xD;
      screening/pretreatment visit which may be performed on the same day as the treatment visit.&#xD;
      Subjects may receive up to 4 treatments on the face with the PicoSure device.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 27, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correct Identification of Baseline Photographs vs. Photographs Taken 3 months Post Last Treatment</measure>
    <time_frame>3 month follow up</time_frame>
    <description>Blinded independent reviewers will perform a photographic evaluation in which they will be asked to identify pre-treatment images when compared to post treatment images. The percentage of photographs that were correctly identified as either baseline photographs or photographs taken at the 3 month follow up will be reported.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pigmentation</condition>
  <condition>Wrinkle</condition>
  <arm_group>
    <arm_group_label>PicoSure Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The PicoSure device will be used on the face for the treatment of pigmentation and mild to moderate wrinkles.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF Non-Invasive Treatment</intervention_name>
    <description>Self-controlled single-arm group using the PicoSure device.</description>
    <arm_group_label>PicoSure Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A healthy male or female 18 - 65 years of age.&#xD;
&#xD;
          -  Willing to undergo treatments for pigmentation and/or mild to moderate wrinkles on the&#xD;
             face with the PicoSure device.&#xD;
&#xD;
          -  Understands and accepts obligation not to receive any other procedures on the&#xD;
             treatment area through the length of the study.&#xD;
&#xD;
          -  Understands and accepts the obligation and is logistically able to be present for all&#xD;
             visits.&#xD;
&#xD;
          -  Is willing to comply with all requirements of the study and sign the informed consent&#xD;
             document.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Is pregnant or of childbearing potential and not using medically effective birth&#xD;
             control, or has been pregnant in the last 3 months, currently breast feeding or&#xD;
             planning a pregnancy during the study.&#xD;
&#xD;
          -  The subject is hypersensitive to light in the near infrared wavelength region.&#xD;
&#xD;
          -  The subject takes medication which is known to increase sensitivity to sunlight.&#xD;
&#xD;
          -  The subject has seizure disorders triggered by light.&#xD;
&#xD;
          -  The subject takes or has taken oral isotretinoin, such as AccutaneÂ®, within the last&#xD;
             six months.&#xD;
&#xD;
          -  The subject has an active localized or systemic infection, or an open wound in area&#xD;
             being treated.&#xD;
&#xD;
          -  The subject has a significant systemic illness, such as lupus, or an illness localized&#xD;
             in area being treated.&#xD;
&#xD;
          -  The subject has common acquired nevi that are predisposed to the development of&#xD;
             malignant melanoma.&#xD;
&#xD;
          -  The subject has herpes simplex in the area being treated.&#xD;
&#xD;
          -  The subject is receiving or has received gold therapy.&#xD;
&#xD;
          -  The subject is currently enrolled in an investigational drug or device trial, or has&#xD;
             received an investigational drug or been treated with an investigational device within&#xD;
             in the area to be treated 6 months to entering this study.&#xD;
&#xD;
          -  The subject has any condition or is in a situation which in the investigators opinion&#xD;
             may put the subject at significant risk, may confound study results or may interfere&#xD;
             significantly with the subject's participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Civiok</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jamie Trimper</last_name>
    <phone>978-256-4200</phone>
    <email>jamie.trimper@cynosure.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>New Jersey Plastic Surgery</name>
      <address>
        <city>Montclair</city>
        <state>New Jersey</state>
        <zip>07042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barry DiBernardo</last_name>
    </contact>
    <investigator>
      <last_name>Barry DiBernardo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>May 5, 2021</last_update_submitted>
  <last_update_submitted_qc>May 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

